144 related articles for article (PubMed ID: 8386772)
1. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
3. Human rhinovirus 3 at 3.0 A resolution.
Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
[TBL] [Abstract][Full Text] [Related]
4. Human rhinovirus 14 complexed with fragments of active antiviral compounds.
Bibler-Muckelbauer JK; Kremer MJ; Rossmann MG; Diana GD; Dutko FJ; Pevear DC; McKinlay MA
Virology; 1994 Jul; 202(1):360-9. PubMed ID: 8009848
[TBL] [Abstract][Full Text] [Related]
5. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses.
Badger J; Minor I; Oliveira MA; Smith TJ; Rossmann MG
Proteins; 1989; 6(1):1-19. PubMed ID: 2558377
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
Speelman B; Brooks BR; Post CB
Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
[TBL] [Abstract][Full Text] [Related]
8. Structural studies on human rhinovirus 14 drug-resistant compensation mutants.
Hadfield AT; Oliveira MA; Kim KH; Minor I; Kremer MJ; Heinz BA; Shepard D; Pevear DC; Rueckert RR; Rossmann MG
J Mol Biol; 1995 Oct; 253(1):61-73. PubMed ID: 7473717
[TBL] [Abstract][Full Text] [Related]
9. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
[TBL] [Abstract][Full Text] [Related]
10. A novel benzonitrile analogue inhibits rhinovirus replication.
Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.
Arnold E; Rossmann MG
J Mol Biol; 1990 Feb; 211(4):763-801. PubMed ID: 2156077
[TBL] [Abstract][Full Text] [Related]
12. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human rhinovirus serotype 1A (HRV1A).
Kim SS; Smith TJ; Chapman MS; Rossmann MC; Pevear DC; Dutko FJ; Felock PJ; Diana GD; McKinlay MA
J Mol Biol; 1989 Nov; 210(1):91-111. PubMed ID: 2555523
[TBL] [Abstract][Full Text] [Related]
14. Motion of an antiviral compound in a rhinovirus capsid under rotational symmetry boundary conditions.
Yoneda S; Yoneda T; Kurihara Y; Umeyama H
J Mol Graph Model; 2002 Aug; 21(1):19-27. PubMed ID: 12413027
[TBL] [Abstract][Full Text] [Related]
15. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
[TBL] [Abstract][Full Text] [Related]
16. The structure of human rhinovirus 16.
Oliveira MA; Zhao R; Lee WM; Kremer MJ; Minor I; Rueckert RR; Diana GD; Pevear DC; Dutko FJ; McKinlay MA
Structure; 1993 Sep; 1(1):51-68. PubMed ID: 7915182
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
Li Y; Zhou Z; Post CB
Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
[TBL] [Abstract][Full Text] [Related]
18. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.
Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC
Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639
[TBL] [Abstract][Full Text] [Related]
19. Human rhinovirus 14 complexed with antiviral compound R 61837.
Chapman MS; Minor I; Rossmann MG; Diana GD; Andries K
J Mol Biol; 1991 Feb; 217(3):455-63. PubMed ID: 1847215
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
